DRAFT
ICD-10-CM/PCS MS-DRG v41.0 Definitions Manual |
> | |||
Skip to content |
Appendix C: Principal diagnoses which convert CC/MCC to non-CC |
Page 66 of 1375 |
PDX Collection 0837 (continued) | |
L089 | Local infection of the skin and subcutaneous tissue, unspecified |
L448 | Other specified papulosquamous disorders |
L449 | Papulosquamous disorder, unspecified |
L45 | Papulosquamous disorders in diseases classified elsewhere |
L732 | Hidradenitis suppurativa |
L88 | Pyoderma gangrenosum |
L928 | Other granulomatous disorders of the skin and subcutaneous tissue |
L942 | Calcinosis cutis |
L944 | Gottron's papules |
L980 | Pyogenic granuloma |
L983 | Eosinophilic cellulitis [Wells] |
L987 | Excessive and redundant skin and subcutaneous tissue |
L988 | Other specified disorders of the skin and subcutaneous tissue |
L99 | Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
Z1610 | Resistance to unspecified beta lactam antibiotics |
Z1611 | Resistance to penicillins |
Z1612 | Extended spectrum beta lactamase (ESBL) resistance |
Z1619 | Resistance to other specified beta lactam antibiotics |
Z1620 | Resistance to unspecified antibiotic |
Z1621 | Resistance to vancomycin |
Z1622 | Resistance to vancomycin related antibiotics |
Z1623 | Resistance to quinolones and fluoroquinolones |
Z1624 | Resistance to multiple antibiotics |
Z1629 | Resistance to other single specified antibiotic |
Z1630 | Resistance to unspecified antimicrobial drugs |
Z1631 | Resistance to antiparasitic drug(s) |
Z1632 | Resistance to antifungal drug(s) |
Z1633 | Resistance to antiviral drug(s) |
Z16341 | Resistance to single antimycobacterial drug |
Z16342 | Resistance to multiple antimycobacterial drugs |
Z1635 | Resistance to multiple antimicrobial drugs |
Z1639 | Resistance to other specified antimicrobial drug |
PDX Collection 0838 | |
A179 | Tuberculosis of nervous system, unspecified |
A184 | Tuberculosis of skin and subcutaneous tissue |
A1882 | Tuberculosis of other endocrine glands |
A1884 | Tuberculosis of heart |
A1889 | Tuberculosis of other sites |
A482 | Nonpneumonic Legionnaires' disease [Pontiac fever] |
A483 | Toxic shock syndrome |
A484 | Brazilian purpuric fever |
A488 | Other specified bacterial diseases |
A4901 | Methicillin susceptible Staphylococcus aureus infection, unspecified site |
A4902 | Methicillin resistant Staphylococcus aureus infection, unspecified site |
A491 | Streptococcal infection, unspecified site |
A492 | Hemophilus influenzae infection, unspecified site |
A493 | Mycoplasma infection, unspecified site |
A498 | Other bacterial infections of unspecified site |
A499 | Bacterial infection, unspecified |
B781 | Cutaneous strongyloidiasis |
B950 | Streptococcus, group A, as the cause of diseases classified elsewhere |
B951 | Streptococcus, group B, as the cause of diseases classified elsewhere |
B952 | Enterococcus as the cause of diseases classified elsewhere |
B953 | Streptococcus pneumoniae as the cause of diseases classified elsewhere |
B954 | Other streptococcus as the cause of diseases classified elsewhere |
B955 | Unspecified streptococcus as the cause of diseases classified elsewhere |
B9561 | Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere |
B9562 | Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere |
B957 | Other staphylococcus as the cause of diseases classified elsewhere |
B958 | Unspecified staphylococcus as the cause of diseases classified elsewhere |
B960 | Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified elsewhere |
B961 | Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere |
B9620 | Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhere |
B9621 | Shiga toxin-producing Escherichia coli [E. coli] [STEC] O157 as the cause of diseases classified elsewhere |
B9622 | Other specified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere |
B9623 | Unspecified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere |
B9629 | Other Escherichia coli [E. coli] as the cause of diseases classified elsewhere |
B963 | Hemophilus influenzae [H. influenzae] as the cause of diseases classified elsewhere |
B964 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere |
B965 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
B966 | Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhere |
B967 | Clostridium perfringens [C. perfringens] as the cause of diseases classified elsewhere |
B9681 | Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere |
B9682 | Vibrio vulnificus as the cause of diseases classified elsewhere |
B9689 | Other specified bacterial agents as the cause of diseases classified elsewhere |
E832 | Disorders of zinc metabolism |
L02611 | Cutaneous abscess of right foot |
L02612 | Cutaneous abscess of left foot |
L02619 | Cutaneous abscess of unspecified foot |
L02811 | Cutaneous abscess of head [any part, except face] |
L02818 | Cutaneous abscess of other sites |
L0291 | Cutaneous abscess, unspecified |
L03811 | Cellulitis of head [any part, except face] |
L03818 | Cellulitis of other sites |
L03891 | Acute lymphangitis of head [any part, except face] |
L03898 | Acute lymphangitis of other sites |
L0390 | Cellulitis, unspecified |
L0391 | Acute lymphangitis, unspecified |
L080 | Pyoderma |
L0881 | Pyoderma vegetans |
L0882 | Omphalitis not of newborn |
L0889 | Other specified local infections of the skin and subcutaneous tissue |
L089 | Local infection of the skin and subcutaneous tissue, unspecified |
L448 | Other specified papulosquamous disorders |
L449 | Papulosquamous disorder, unspecified |
L45 | Papulosquamous disorders in diseases classified elsewhere |
L732 | Hidradenitis suppurativa |
L88 | Pyoderma gangrenosum |
L928 | Other granulomatous disorders of the skin and subcutaneous tissue |
L942 | Calcinosis cutis |
L944 | Gottron's papules |
L980 | Pyogenic granuloma |
L983 | Eosinophilic cellulitis [Wells] |
L987 | Excessive and redundant skin and subcutaneous tissue |
L988 | Other specified disorders of the skin and subcutaneous tissue |
L99 | Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
Z1610 | Resistance to unspecified beta lactam antibiotics |
Z1611 | Resistance to penicillins |
Z1612 | Extended spectrum beta lactamase (ESBL) resistance |
Z1619 | Resistance to other specified beta lactam antibiotics |
Z1620 | Resistance to unspecified antibiotic |
Z1621 | Resistance to vancomycin |
Z1622 | Resistance to vancomycin related antibiotics |
Z1623 | Resistance to quinolones and fluoroquinolones |
Z1624 | Resistance to multiple antibiotics |
Z1629 | Resistance to other single specified antibiotic |
Z1630 | Resistance to unspecified antimicrobial drugs |
Z1631 | Resistance to antiparasitic drug(s) |
Z1632 | Resistance to antifungal drug(s) |
Z1633 | Resistance to antiviral drug(s) |
Z16341 | Resistance to single antimycobacterial drug |
Z16342 | Resistance to multiple antimycobacterial drugs |
Z1635 | Resistance to multiple antimicrobial drugs |
Z1639 | Resistance to other specified antimicrobial drug |
PDX Collection 0839 | |
A179 | Tuberculosis of nervous system, unspecified |
A184 | Tuberculosis of skin and subcutaneous tissue |
A1882 | Tuberculosis of other endocrine glands |
A1884 | Tuberculosis of heart |
A1889 | Tuberculosis of other sites |
A482 | Nonpneumonic Legionnaires' disease [Pontiac fever] |
A483 | Toxic shock syndrome |
A484 | Brazilian purpuric fever |
A488 | Other specified bacterial diseases |
A4901 | Methicillin susceptible Staphylococcus aureus infection, unspecified site |
A4902 | Methicillin resistant Staphylococcus aureus infection, unspecified site |
A491 | Streptococcal infection, unspecified site |
A492 | Hemophilus influenzae infection, unspecified site |
A493 | Mycoplasma infection, unspecified site |
A498 | Other bacterial infections of unspecified site |
A499 | Bacterial infection, unspecified |
B781 | Cutaneous strongyloidiasis |
B950 | Streptococcus, group A, as the cause of diseases classified elsewhere |
B951 | Streptococcus, group B, as the cause of diseases classified elsewhere |
B952 | Enterococcus as the cause of diseases classified elsewhere |
B953 | Streptococcus pneumoniae as the cause of diseases classified elsewhere |
B954 | Other streptococcus as the cause of diseases classified elsewhere |
B955 | Unspecified streptococcus as the cause of diseases classified elsewhere |
B9561 | Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere |
B9562 | Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere |
B957 | Other staphylococcus as the cause of diseases classified elsewhere |
B958 | Unspecified staphylococcus as the cause of diseases classified elsewhere |
B960 | Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified elsewhere |
B961 | Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere |
B9620 | Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhere |
B9621 | Shiga toxin-producing Escherichia coli [E. coli] [STEC] O157 as the cause of diseases classified elsewhere |
B9622 | Other specified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere |
B9623 | Unspecified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere |
B9629 | Other Escherichia coli [E. coli] as the cause of diseases classified elsewhere |
B963 | Hemophilus influenzae [H. influenzae] as the cause of diseases classified elsewhere |
B964 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere |
B965 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
B966 | Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhere |
B967 | Clostridium perfringens [C. perfringens] as the cause of diseases classified elsewhere |
B9681 | Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere |
B9682 | Vibrio vulnificus as the cause of diseases classified elsewhere |
B9689 | Other specified bacterial agents as the cause of diseases classified elsewhere |
E832 | Disorders of zinc metabolism |
L02811 | Cutaneous abscess of head [any part, except face] |
L02818 | Cutaneous abscess of other sites |
L0291 | Cutaneous abscess, unspecified |
L03811 | Cellulitis of head [any part, except face] |
L03818 | Cellulitis of other sites |
L03891 | Acute lymphangitis of head [any part, except face] |
L03898 | Acute lymphangitis of other sites |
L0390 | Cellulitis, unspecified |
L0391 | Acute lymphangitis, unspecified |
L080 | Pyoderma |
L0881 | Pyoderma vegetans |
L0882 | Omphalitis not of newborn |
L0889 | Other specified local infections of the skin and subcutaneous tissue |
L089 | Local infection of the skin and subcutaneous tissue, unspecified |
L448 | Other specified papulosquamous disorders |
L449 | Papulosquamous disorder, unspecified |
L45 | Papulosquamous disorders in diseases classified elsewhere |
L732 | Hidradenitis suppurativa |
L88 | Pyoderma gangrenosum |
L928 | Other granulomatous disorders of the skin and subcutaneous tissue |
L942 | Calcinosis cutis |
L944 | Gottron's papules |
L980 | Pyogenic granuloma |
L983 | Eosinophilic cellulitis [Wells] |
L987 | Excessive and redundant skin and subcutaneous tissue |
L988 | Other specified disorders of the skin and subcutaneous tissue |
L99 | Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
Z1610 | Resistance to unspecified beta lactam antibiotics |
Z1611 | Resistance to penicillins |
Z1612 | Extended spectrum beta lactamase (ESBL) resistance |
Z1619 | Resistance to other specified beta lactam antibiotics |
Z1620 | Resistance to unspecified antibiotic |
Z1621 | Resistance to vancomycin |
Z1622 | Resistance to vancomycin related antibiotics |
Z1623 | Resistance to quinolones and fluoroquinolones |
Z1624 | Resistance to multiple antibiotics |
Z1629 | Resistance to other single specified antibiotic |
Z1630 | Resistance to unspecified antimicrobial drugs |
Z1631 | Resistance to antiparasitic drug(s) |
Z1632 | Resistance to antifungal drug(s) |
Z1633 | Resistance to antiviral drug(s) |
Z16341 | Resistance to single antimycobacterial drug |
Z16342 | Resistance to multiple antimycobacterial drugs |
Z1635 | Resistance to multiple antimicrobial drugs |
Z1639 | Resistance to other specified antimicrobial drug |
PDX Collection 0840 | |
A179 | Tuberculosis of nervous system, unspecified |
A184 | Tuberculosis of skin and subcutaneous tissue |
A1882 | Tuberculosis of other endocrine glands |
A1884 | Tuberculosis of heart |
A1889 | Tuberculosis of other sites |
A482 | Nonpneumonic Legionnaires' disease [Pontiac fever] |
A483 | Toxic shock syndrome |
A484 | Brazilian purpuric fever |
A488 | Other specified bacterial diseases |
A4901 | Methicillin susceptible Staphylococcus aureus infection, unspecified site |
A4902 | Methicillin resistant Staphylococcus aureus infection, unspecified site |
A491 | Streptococcal infection, unspecified site |
A492 | Hemophilus influenzae infection, unspecified site |
A493 | Mycoplasma infection, unspecified site |
A498 | Other bacterial infections of unspecified site |
A499 | Bacterial infection, unspecified |
B781 | Cutaneous strongyloidiasis |
B950 | Streptococcus, group A, as the cause of diseases classified elsewhere |
B951 | Streptococcus, group B, as the cause of diseases classified elsewhere |
B952 | Enterococcus as the cause of diseases classified elsewhere |
B953 | Streptococcus pneumoniae as the cause of diseases classified elsewhere |
B954 | Other streptococcus as the cause of diseases classified elsewhere |
B955 | Unspecified streptococcus as the cause of diseases classified elsewhere |
B9561 | Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere |
B9562 | Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere |
B957 | Other staphylococcus as the cause of diseases classified elsewhere |
B958 | Unspecified staphylococcus as the cause of diseases classified elsewhere |
B960 | Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified elsewhere |
B961 | Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere |
B9620 | Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhere |
B9621 | Shiga toxin-producing Escherichia coli [E. coli] [STEC] O157 as the cause of diseases classified elsewhere |
B9622 | Other specified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere |
B9623 | Unspecified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere |
B9629 | Other Escherichia coli [E. coli] as the cause of diseases classified elsewhere |
B963 | Hemophilus influenzae [H. influenzae] as the cause of diseases classified elsewhere |
B964 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere |
B965 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
B966 | Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhere |
B967 | Clostridium perfringens [C. perfringens] as the cause of diseases classified elsewhere |
B9681 | Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere |
B9682 | Vibrio vulnificus as the cause of diseases classified elsewhere |
B9689 | Other specified bacterial agents as the cause of diseases classified elsewhere |
E832 | Disorders of zinc metabolism |
L02811 | Cutaneous abscess of head [any part, except face] |
L02818 | Cutaneous abscess of other sites |
L0291 | Cutaneous abscess, unspecified |
L03211 | Cellulitis of face |
L03213 | Periorbital cellulitis |
L03811 | Cellulitis of head [any part, except face] |
L03818 | Cellulitis of other sites |
L03891 | Acute lymphangitis of head [any part, except face] |
L03898 | Acute lymphangitis of other sites |
L0390 | Cellulitis, unspecified |
L0391 | Acute lymphangitis, unspecified |
L080 | Pyoderma |
L0881 | Pyoderma vegetans |
L0882 | Omphalitis not of newborn |
L0889 | Other specified local infections of the skin and subcutaneous tissue |
L089 | Local infection of the skin and subcutaneous tissue, unspecified |
L448 | Other specified papulosquamous disorders |
L449 | Papulosquamous disorder, unspecified |
L45 | Papulosquamous disorders in diseases classified elsewhere |
L732 | Hidradenitis suppurativa |
L88 | Pyoderma gangrenosum |
L928 | Other granulomatous disorders of the skin and subcutaneous tissue |
L942 | Calcinosis cutis |
L944 | Gottron's papules |
L980 | Pyogenic granuloma |
L983 | Eosinophilic cellulitis [Wells] |
L987 | Excessive and redundant skin and subcutaneous tissue |
L988 | Other specified disorders of the skin and subcutaneous tissue |
L99 | Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
Z1610 | Resistance to unspecified beta lactam antibiotics |
Z1611 | Resistance to penicillins |
Z1612 | Extended spectrum beta lactamase (ESBL) resistance |
Z1619 | Resistance to other specified beta lactam antibiotics |
Z1620 | Resistance to unspecified antibiotic |
Z1621 | Resistance to vancomycin |
Z1622 | Resistance to vancomycin related antibiotics |
Z1623 | Resistance to quinolones and fluoroquinolones |
Z1624 | Resistance to multiple antibiotics |
Z1629 | Resistance to other single specified antibiotic |
Z1630 | Resistance to unspecified antimicrobial drugs |
Z1631 | Resistance to antiparasitic drug(s) |
Z1632 | Resistance to antifungal drug(s) |
Z1633 | Resistance to antiviral drug(s) |
Z16341 | Resistance to single antimycobacterial drug |
Z16342 | Resistance to multiple antimycobacterial drugs |
Z1635 | Resistance to multiple antimicrobial drugs |
Z1639 | Resistance to other specified antimicrobial drug |
PDX Collection 0841 | |
L0501 | Pilonidal cyst with abscess |
L0502 | Pilonidal sinus with abscess |
L0591 | Pilonidal cyst without abscess |
L0592 | Pilonidal sinus without abscess |
L448 | Other specified papulosquamous disorders |
L449 | Papulosquamous disorder, unspecified |
L45 | Papulosquamous disorders in diseases classified elsewhere |
L942 | Calcinosis cutis |
L944 | Gottron's papules |
L987 | Excessive and redundant skin and subcutaneous tissue |
L988 | Other specified disorders of the skin and subcutaneous tissue |
L99 | Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
PDX Collection 0842 | |
L100 | Pemphigus vulgaris |
L101 | Pemphigus vegetans |
L102 | Pemphigus foliaceous |
L103 | Brazilian pemphigus [fogo selvagem] |
L104 | Pemphigus erythematosus |
L105 | Drug-induced pemphigus |
L1081 | Paraneoplastic pemphigus |
L1089 | Other pemphigus |
L109 | Pemphigus, unspecified |
L120 | Bullous pemphigoid |
L121 | Cicatricial pemphigoid |
L128 | Other pemphigoid |
L129 | Pemphigoid, unspecified |
L138 | Other specified bullous disorders |
L139 | Bullous disorder, unspecified |
L14 | Bullous disorders in diseases classified elsewhere |
L448 | Other specified papulosquamous disorders |
L449 | Papulosquamous disorder, unspecified |
L45 | Papulosquamous disorders in diseases classified elsewhere |
L942 | Calcinosis cutis |
L944 | Gottron's papules |
L987 | Excessive and redundant skin and subcutaneous tissue |
L988 | Other specified disorders of the skin and subcutaneous tissue |
L99 | Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
PDX Collection 0843 | |
L00 | Staphylococcal scalded skin syndrome |
L1230 | Acquired epidermolysis bullosa, unspecified |
L1231 | Epidermolysis bullosa due to drug |
L1235 | Other acquired epidermolysis bullosa |
L26 | Exfoliative dermatitis |
L304 | Erythema intertrigo |
L448 | Other specified papulosquamous disorders |
L449 | Papulosquamous disorder, unspecified |
L45 | Papulosquamous disorders in diseases classified elsewhere |
L510 | Nonbullous erythema multiforme |
L511 | Stevens-Johnson syndrome |
L512 | Toxic epidermal necrolysis [Lyell] |
L513 | Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome |
L518 | Other erythema multiforme |
L519 | Erythema multiforme, unspecified |
L52 | Erythema nodosum |
L530 | Toxic erythema |
L531 | Erythema annulare centrifugum |
L532 | Erythema marginatum |
L533 | Other chronic figurate erythema |
L538 | Other specified erythematous conditions |
L539 | Erythematous condition, unspecified |
L54 | Erythema in diseases classified elsewhere |
L710 | Perioral dermatitis |
L711 | Rhinophyma |
L718 | Other rosacea |
L719 | Rosacea, unspecified |
L920 | Granuloma annulare |
L930 | Discoid lupus erythematosus |
L931 | Subacute cutaneous lupus erythematosus |
L932 | Other local lupus erythematosus |
L942 | Calcinosis cutis |
L944 | Gottron's papules |
L951 | Erythema elevatum diutinum |
L982 | Febrile neutrophilic dermatosis [Sweet] |
L987 | Excessive and redundant skin and subcutaneous tissue |
L988 | Other specified disorders of the skin and subcutaneous tissue |
L99 | Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
PDX Collection 0844 | |
L493 | Exfoliation due to erythematous condition involving 30-39 percent of body surface |
PDX Collection 0845 | |
L494 | Exfoliation due to erythematous condition involving 40-49 percent of body surface |
PDX Collection 0846 | |
L495 | Exfoliation due to erythematous condition involving 50-59 percent of body surface |
PDX Collection 0847 | |
L496 | Exfoliation due to erythematous condition involving 60-69 percent of body surface |
PDX Collection 0848 | |
L497 | Exfoliation due to erythematous condition involving 70-79 percent of body surface |
PDX Collection 0849 | |
L498 | Exfoliation due to erythematous condition involving 80-89 percent of body surface |
PDX Collection 0850 | |
L499 | Exfoliation due to erythematous condition involving 90 or more percent of body surface |
PDX Collection 0851 | |
L1230 | Acquired epidermolysis bullosa, unspecified |
L1231 | Epidermolysis bullosa due to drug |
L1235 | Other acquired epidermolysis bullosa |
L448 | Other specified papulosquamous disorders |
L449 | Papulosquamous disorder, unspecified |
L45 | Papulosquamous disorders in diseases classified elsewhere |
L510 | Nonbullous erythema multiforme |
L511 | Stevens-Johnson syndrome |
L512 | Toxic epidermal necrolysis [Lyell] |
L513 | Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome |
L518 | Other erythema multiforme |
L519 | Erythema multiforme, unspecified |
L52 | Erythema nodosum |
L530 | Toxic erythema |
L531 | Erythema annulare centrifugum |
L532 | Erythema marginatum |
L533 | Other chronic figurate erythema |
L710 | Perioral dermatitis |
L711 | Rhinophyma |
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 01 Mar 2023 06:12:40 CMS, code-revision=344, description-revision=1357 |